KOS Pharmaceuticals
Cranbury
About KOS Pharmaceuticals
KOS Pharmaceuticals manufactures prescription products for the treatment of chronic cardiovascular diseases. Their products are used treatment of primary hypercholesterolemia and mixed dyslipidemia, mixed lipid disorders, and non dihydropyridine calcium channel blocker, enabling doctors to treat hypertension and chronic stable angina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Funding stage: M&A
- Last round: Seed (Jan 2004)
- Website: kospharm.com
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/kos-pharmaceuticals-2435377 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.